tiprankstipranks
Advertisement
Advertisement
PremiumCompany AnnouncementsAlmirall Schedules Webcast to Present 2025 Financial Results
2M ago
Premium
Company Announcements
Almirall Publishes 2025 Corporate Governance Report in Enhanced Narrative Format
2M ago
Premium
Company Announcements
Almirall’s 2025 Pay Report Highlights Strong Dermatology Growth and Governance Backing
2M ago
Almirall Advances LAD603 Phase 2 Alopecia Trial, Adding Optionality to Its Dermatology Pipeline
PremiumCompany AnnouncementsAlmirall Advances LAD603 Phase 2 Alopecia Trial, Adding Optionality to Its Dermatology Pipeline
3M ago
Almirall Completes Phase 1 Study on LAD603: What Investors Need to Know
Premium
Company Announcements
Almirall Completes Phase 1 Study on LAD603: What Investors Need to Know
4M ago
Almirall’s Phase 1 Study on LAD191: A Potential Game-Changer in Autoimmune Treatment
Premium
Company Announcements
Almirall’s Phase 1 Study on LAD191: A Potential Game-Changer in Autoimmune Treatment
4M ago
Almirall’s Study on Tildrakizumab: A Potential Game-Changer in Psoriasis Treatment?
PremiumCompany AnnouncementsAlmirall’s Study on Tildrakizumab: A Potential Game-Changer in Psoriasis Treatment?
10M ago
Almirall Completes Capital Increase to Enhance Market Position
Premium
Company Announcements
Almirall Completes Capital Increase to Enhance Market Position
10M ago
Almirall (0O9B) Declares Q2 Dividend: Important Details for Shareholders
Premium
Dividends
Almirall (0O9B) Declares Q2 Dividend: Important Details for Shareholders
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100